Patents by Inventor G. Erik Jagdmann, Jr.

G. Erik Jagdmann, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted fused and bridged bicyclic compounds as therapeutic agents
    Patent number: 5583221
    Abstract: Compounds having the formula ##STR1## methods for using such compounds to inhibit protein kinase C in animals, including man are useful as inhibitors of protein kinase C. Also disclosed are pharmaceutical compositions including such compounds and compounds having the formula.
    Type: Grant
    Filed: February 23, 1995
    Date of Patent: December 10, 1996
    Assignee: Eli Lilly and Company
    Inventors: Hong Hu, G. Erik Jagdmann, Jr., Jose S. Mendoza
  • Vicinal-substituted carbocyclic compounds as therapeutic agents
    Patent number: 5432198
    Abstract: Compounds having the formula ##STR1## are useful as inhibitors of protein kinase C. Also disclosed are pharmaceutical compositions including such compounds and methods for using such compounds to inhibit protein kinase C in animals, including man.
    Type: Grant
    Filed: August 18, 1994
    Date of Patent: July 11, 1995
    Assignee: Sphinx Pharmaceuticals Corporation
    Inventor: G. Erik Jagdmann, Jr.